Back to Search
ILDIKO LINGVAY, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1447216916IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
L5435(TX)
Education
OTHER
Class of 1998
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (9)
Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study.
PMID 31803482·BMJ Open Diabetes Res Care·2019
2-rct
Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
PMID 27273731·JAMA Intern Med·2016
2-rct
Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.
PMID 26909799·J Clin Endocrinol Metab·2016
2-rct
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?
PMID 19592630·Diabetes Care·2009
2-rct
Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted.
PMID 17362692·J Investig Med·2007
3-trial
Trends in thyroid cancer demographics and surgical therapy in the United States.
PMID 18063063·Surgery·2007
8-other
Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes.
PMID 17850734·J Investig Med·2007
2-rct
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.
PMID 17698735·Circulation·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5323 HARRY HINES BLVD
DALLAS, TX 75390 - Phone
- (214) 645-2868
Quick Facts
- NPI
- 1447216916
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Clinical Trials
- 2
- Publications
- 9
Are you this provider?
Claim Your Profile